Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6037329 | 0.86 | HSD17B10 (0.33) | HSD17B10TDP1 | |
| SCHEMBL1806298 | 0.83 | HSD17B10 (0.35) | HSD17B10TDP1 | |
| SCHEMBL269320 | 0.80 | HSD17B10 (0.30) | HSD17B10TDP1 | |
| SCHEMBL7701977 | 0.77 | HSD17B10 (0.31) | HSD17B10TDP1 | |
| SCHEMBL332508 | 0.76 | — | — | |
| SCHEMBL8418941 | 0.74 | — | — | |
| SCHEMBL145162 | 0.74 | — | — | |
| SCHEMBL537647 | 0.74 | — | — | |
| SCHEMBL692373 | 0.74 | CES2 (0.31) | — | |
| SCHEMBL8377546 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240409563-A1 | HIGH PURITY POLYSILOXANE MACROMERS AND METHOD FOR MAKING THE SAME | GELEST, INC. | 2024-12-12 | — | — | US | claimed |
| EP-4448536-A1 | HIGH PURITY POLYSILOXANE MACROMERS AND METHOD FOR MAKING THE SAME | GELEST, INC. (US) | 2024-10-23 | — | — | EP | claimed |
| WO-2023113779-A1 | HIGH PURITY POLYSILOXANE MACROMERS AND METHOD FOR MAKING THE SAME | GELEST, INC. (US) | 2023-06-22 | — | — | WO | claimed |
| US-20230183273-A1 | HIGH PURITY POLYSILOXANE MACROMERS AND METHOD FOR MAKING THE SAME | GELEST, INC. | 2023-06-15 | — | — | US | claimed |
| US-20240409563-A1 | HIGH PURITY POLYSILOXANE MACROMERS AND METHOD FOR MAKING THE SAME | GELEST, INC. | 2024-12-12 | — | — | US | disclosed |
| EP-4448536-A1 | HIGH PURITY POLYSILOXANE MACROMERS AND METHOD FOR MAKING THE SAME | GELEST, INC. (US) | 2024-10-23 | — | — | EP | disclosed |
| CN-118401532-A | High-purity polysiloxane macromer and preparation method thereof | 盖列斯特有限公司 | 2024-07-26 | — | — | CN | disclosed |
| WO-2023113779-A1 | HIGH PURITY POLYSILOXANE MACROMERS AND METHOD FOR MAKING THE SAME | GELEST, INC. (US) | 2023-06-22 | — | — | WO | disclosed |
| US-20230183273-A1 | HIGH PURITY POLYSILOXANE MACROMERS AND METHOD FOR MAKING THE SAME | GELEST, INC. | 2023-06-15 | — | — | US | disclosed |
| US-20060222869-A1 | Electropen lithography | ENERGY, UNITED STATES DEPARTMENT | 2006-10-05 | — | — | US | disclosed |
| US-5319051-A | A hydrosiloxy or alkyenylsiloxy endcapped polysilane homo-or copolymer; chemical intermediates | SHIN-ETSU CHEMICAL COMPANY, LIMITED (JP) | 1994-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240409563-A1 | HIGH PURITY POLYSILOXANE MACROMERS AND METHOD FOR MAKING THE SAME | SSRP1, RPLP2, RPLP1 | HSD17B10 2634/4885TDP1 676/4885 |
| US-20230183273-A1 | HIGH PURITY POLYSILOXANE MACROMERS AND METHOD FOR MAKING THE SAME | SSRP1, RPLP2, RPLP1 | HSD17B10 2634/4885TDP1 676/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.